Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
- 1 February 1998
- journal article
- Published by Elsevier in The Lancet
- Vol. 351 (9102) , 550-554
- https://doi.org/10.1016/s0140-6736(97)10295-1
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- A prospective study of minimal residual disease in childhood B‐lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapseBritish Journal of Haematology, 1997
- Measurement of Residual Leukemia during Remission in Childhood Acute Lymphoblastic LeukemiaNew England Journal of Medicine, 1997
- Childhood LeukemiasNew England Journal of Medicine, 1995
- AnnotationBritish Journal of Haematology, 1995
- Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysisBlood, 1994
- Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genesBlood, 1994
- A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemiaBlood, 1994
- Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of inductionThe Lancet, 1994
- Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reactionBlood, 1993
- Detection of minimal residual disease in T-cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapseBlood, 1991